GL1X · GenesisL1 explorer

MolNFT v1 · #189140 · protein

Crystal structure of cmet in complex with a novel inhibitor

7V3S · Hepatocyte growth factor receptor: “Crystal structure of cmet in complex with a novel inhibitor”. X-ray diffraction, 1 ligand (5I9), 1 pocket (best druggability 0.73). MolNFT v1 #189140 on GenesisL1: 3D structure, binding sites and…

PDB
7V3S
Type
protein
Length
284 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hepatocyte growth factor receptor
EC
2.7.10.1
UniProt
P08581
Ligands
5I9
Pockets
1 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHepatocyte growth factor receptor (EC 2.7.10.1)protein28442% helix, 16% strandP08581

Ligands and binding sites

  • 5I9 · ~{N}1'-[3-fluoranyl-4-(10~{H}-pyrido[3,2-B][1, 4]benzoxazin-4-yloxy)phenyl]-~{N}1-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14290.730.83585I9

Compared structures

  • 7V3S · Crystal structure of CMET in complex with a novel inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.